CLINICAL_TRIALS
trial_result
· 2013-05-08
Clinical Trial Update: An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain [Phase 3]
Summary
A Phase 3 study evaluated the efficacy and safety of fentanyl JNS020QD for cancer pain. The trial has completed and results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Pain, Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-05-08